Stelara 45 MG/0.5 ML syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DR26FM13N
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,409
Award facts
- Contract value 100% obligated
- $13,408.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,408.72 to AmerisourceBergen Drug Corp for the supply of Stelara 45 mg/0.5 mL syringes on November 14, 2025, with an ultimate completion date of November 17, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is being performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime contract vehicle valued through December 2026 that enables the company to supply a comprehensive range of pharmaceuticals and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal medical procurement vendor for the Defense Logistics Agency and other government healthcare systems. The company's established relationship with DLA through its overarching IDC demonstrates its capability to meet federal procurement requirements for specialty medications, brand-name and generic drugs, and specialized medical supplies across multiple therapeutic domains. This delivery order for Stelara, an immunosuppressant therapy, exemplifies the company's role in supporting military and veteran healthcare needs through the DLA's medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FM13N?
SPE2DR26FM13N was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 14, 2025.
How much is contract SPE2DR26FM13N worth?
The government has obligated $13,409 on SPE2DR26FM13N.
Is contract SPE2DR26FM13N an order under another contract?
Yes. SPE2DR26FM13N is a delivery order under SPE2DR25D2007, an indefinite delivery contract.
Was contract SPE2DR26FM13N competed?
The extent of competition for SPE2DR26FM13N was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award